ACTIVE

Apotheek Werchter

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
31,9 k €
+642,5 %over 1 year
Gross margin
129,6 k €
+48,1 %over 1 year
Equity
210,7 k €
+0,4 %over 1 year
Workforce
1,0 ETP
-9,1 %over 1 year

Identity

Source · BCE/KBO

Apotheek Werchter is a Public limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Rotselaar. It employs on average 1,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0832.197.543
Incorporation
22/12/2010
Legal form
Public limited company
Registered office
Tweebruggenstraat 7
3118 Rotselaar · FlandreSee on map
Contributed capital
61 500,00 €
Latest accounts
31/12/2025
Average workforce
1,0 ETP
Joint committees (2)
  • 313
  • 31300
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 15 financial years

20252024202320222021
Income statement
Gross margin129,6 k €87,5 k €88,7 k €113,5 k €102,3 k €
EBITDA46,7 k €14 k €-8,3 k €45,3 k €8,4 k €
Operating result41,5 k €7,6 k €-14,8 k €40,4 k €5 k €
Net result31,9 k €4,3 k €-16,1 k €40,4 k €6,9 k €
Balance sheet
Equity210,7 k €209,8 k €205,6 k €221,6 k €241,2 k €
Total assets402,8 k €400,1 k €352,3 k €486,2 k €340,5 k €
Cash84,7 k €70,5 k €29,9 k €55 k €57,7 k €
Debts191,3 k €188,5 k €146,4 k €264,6 k €99,3 k €
Other
Workforce1,0 ETP1,1 ETP1,7 ETP1,5 ETP1,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 13 ended

Active mandates

FARMALIEN

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0713.889.019

Represented by Dupont Elien

Active
Pharma-Godfroid

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0763.498.777

Represented by Godfroid Laurence

Active

Ended mandates

FARMALIEN

Director · since 01 juillet 2021 · until 25 juin 2027 · 0713.889.019

Represented by Dupont ELIEN

Ended
FARMALIEN

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0713.889.019

Represented by Dupont ELIEN

Ended
Pharma-Godfroid

Director · since 01 juillet 2021 · until 25 juin 2027 · 0763.498.777

Represented by Godfroid LAURENCE

Ended
Pharma-Godfroid

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0763.498.777

Represented by Godfroid LAURENCE

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202618/07/202529/08/202407/07/202305/07/202231/05/2021
General meeting24/06/202624/06/202530/06/202424/06/202324/06/202208/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202524/06/202614/07/2026DutchPDF
Abridged model31/12/202424/06/202518/07/2025DutchPDF
Abridged model31/12/202330/06/202429/08/2024DutchPDF
Abridged model31/12/202224/06/202307/07/2023DutchPDF
Abridged model31/12/202124/06/202205/07/2022DutchPDF
Abridged model31/12/202008/04/202131/05/2021DutchPDF
Abridged model31/12/201924/06/202003/07/2020DutchPDF
Abridged model31/12/201824/06/201901/07/2019DutchPDF
Abridged model31/12/201725/06/201806/07/2018DutchPDF
Abridged model31/12/201624/06/201726/06/2017DutchPDF
Abridged model31/12/201524/06/201628/06/2016DutchPDF
Abridged model31/12/201424/06/201513/08/2015DutchPDF
Abridged model31/12/201324/06/201428/08/2014DutchPDF
Abridged model31/12/201224/06/201330/08/2013DutchPDF
Abridged model31/12/201125/06/201228/06/2012DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 13 ended

Active mandates

FARMALIEN

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0713.889.019

Represented by Dupont Elien

Active
Pharma-Godfroid

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0763.498.777

Represented by Godfroid Laurence

Active

Ended mandates

FARMALIEN

Director · since 01 juillet 2021 · until 25 juin 2027 · 0713.889.019

Represented by Dupont ELIEN

Ended
FARMALIEN

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0713.889.019

Represented by Dupont ELIEN

Ended
Pharma-Godfroid

Director · since 01 juillet 2021 · until 25 juin 2027 · 0763.498.777

Represented by Godfroid LAURENCE

Ended
Pharma-Godfroid

Director · since 01 juillet 2021 · until 01 juillet 2027 · 0763.498.777

Represented by Godfroid LAURENCE

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares28/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - KAPITAAL - AANDELEN
    PDF
  • Mandates19/07/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/07/2016
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other27/09/2012
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates31/08/2012
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/07/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other04/01/2011
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202531,9 k €↑
  2. 2024
    Annual accounts 20244,3 k €↑
  3. 2023
    Annual accounts 2023-16,1 k €↓
  4. 2022
    Annual accounts 202240,4 k €↑
  5. 2021
    Annual accounts 20216,9 k €↓
  6. 2020
    Annual accounts 2020110 k €↑
  7. 2019
    Annual accounts 2019107,8 k €↓
  8. 2018
    Annual accounts 2018120,3 k €↑
  9. 2017
    Annual accounts 201797,8 k €↓
  10. 2016
    Annual accounts 2016142,2 k €↑
  11. 2015
    Annual accounts 2015104,1 k €↑
  12. 2014
    Annual accounts 2014101,2 k €↑
  13. 2013
    Annual accounts 201371,8 k €↓
  14. 2012
    Annual accounts 201284 k €↓
  15. 2011
    Annual accounts 2011224 k €
  16. 22/12/2010
    IncorporationPublic limited company